Inhibitory effects of T/L-type calcium channel blockers on tubulointerstitial fibrosis in obstructed kidneys in rats

Urology

Volumn 77, Issue 1, 2011, Pages 249.e9-249.e15

  Matsuda, Hirohisa ^a   Mori, Tatsuhiko ^a   Kurumazuka, Daisuke ^a   Kitada, Kento ^a   Hayashi, Tetsuya ^a   Nagatoya, Katsuyuki ^a   Inoue, Toru ^a   Ukimura, Akira ^a   Matsumura, Yasuo ^a   Ishizaka, Nobukazu ^a   Kitaura, Yasushi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CONNECTIVE TISSUE GROWTH FACTOR; EFONIDIPINE; MESSENGER RNA; NIFEDIPINE; P22PHOX PROTEIN; P47PHOX PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFECT; FIBROGENESIS; GENE EXPRESSION; KIDNEY FIBROSIS; KIDNEY MASS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL PROTECTION; TREATMENT OUTCOME; TUBULOINTERSTITIAL FIBROSIS; UNILATERAL URETERAL OBSTRUCTION; URETER OBSTRUCTION;

EID: 78650855031     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.07.496     Document Type: Article

References (30)

1. K.A. Nath The tubulointerstitium in progressive renal disease Kidney Int 54 1998 992 994
2. A.H. Bani-Hani, J.A. Leslie, and H. Asanuma IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis Kidney Int 76 2009 500 511
3. S. Klahr New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy Am J Kidney Dis 18 1991 689 699
4. G.P. Sun, M. Kohno, and P. Guo Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury J Am Soc Nephrol 17 2006 2193 2201
5. H. Trachtman, A.C. Weiser, and E. Valderrama Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction J Urol 172 2004 1590 1594
6. K. Imagawa, S. Okayama, and M. Takaoka Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells J Cardiovasc Pharmacol 47 2006 133 138
7. S. Okayama, K. Imagawa, and N. Naya Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers Hypertens Res 29 2006 493 497
8. J.D. Dietz, S. Du, and C.W. Bolten A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity Hypertension 51 2008 742 748
9. T. Iwai, K. Kitamoto, and K. Teramoto Cobalt protoporphyrin attenuates rat obstructive nephropathy: role of cellular infiltration Urology 72 2008 432 438
10. M. Hultstrom, S. Leh, and T. Skogstrand Upregulation of tissue inhibitor of metalloproteases-1 (TIMP-1) and procollagen-N-peptidase in hypertension-induced renal damage Nephrol Dial Transplant 23 2008 896 903
11. T. Mori, D. Kurumazuka, and C. Matsumoto Dietary salt restriction activates mineralocorticoid receptor signaling in volume-overloaded heart failure Eur J Pharmacol 623 2009 84 88
12. T. Tanaka, Y. Nishiyama, and K. Okada Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion Lab Invest 77 1997 145 155
13. R.L. Chevalier, M.S. Forbes, and B.A. Thornhill Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy Kidney Int 75 2009 1145 1152
14. B. Pat, T. Yang, and C. Kong Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants Kidney Int 67 2005 931 943
15. S.D. Ricardo, G. Ding, and M. Eufemio Antioxidant expression in experimental hydronephrosis: role of mechanical stretch and growth factors Am J Physiol 272 1997 F789 F798
16. N. Kawada, T. Moriyama, and A. Ando Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction Kidney Int 56 1999 1004 1013
17. A. Kamijo-Ikemori, T. Sugaya, and A. Obama Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction Am J Pathol 169 2006 1107 1117
18. B. Yuan, M. Liang, and Z. Yang Gene expression reveals vulnerability to oxidative stress and interstitial fibrosis of renal outer medulla to nonhypertensive elevations of ANG. II Am J Physiol Regul Integr Comp Physiol 284 2003 R1219 R1230
19. K. Fukuo, J. Yang, and O. Yasuda Nifedipine indirectly upregulates superoxide dismutase expression in endothelial cells via vascular smooth muscle cell-dependent pathways Circulation 106 2002 356 361
20. L. Chen, W.H. Haught, and B. Yang Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine J Am Coll Cardiol 30 1997 569 575
21. T. Tanaka, T. Tsutamoto, and H. Sakai Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension Hypertens Res 30 2007 691 697
22. S. Klahr, and J. Morrissey Obstructive nephropathy and renal fibrosis Am J Physiol Ren Physiol 283 2002 F861 F875
23. L. Yanes, D. Romero, and R. Iliescu Systemic arterial pressure response to two weeks of tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress Am J Physiol Regul Integr Comp Physiol 288 2005 R903 R908
24. W.J. Welch, M. Mendonca, and J. Blau Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat Kidney Int 68 2005 179 187
25. M. Nagase, H. Matsui, and S. Shibata Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress Hypertension 50 2007 877 883
26. T. Konda, A. Enomoto, and S. Aritomi Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm Am J Nephrol 30 2009 155 161
27. A. Takahara, Y. Nakamura, and H. Wagatsuma Long-term blockade of L/N-type (Ca2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart Br J Pharmacol 158 2009 1366 1374
28. T.M. Seccia, C. Maniero, and A.S. Belloni Role of angiotensin II, endothelin-1 and L-type calcium channel in the development of glomerular, tubulointerstitial and perivascular fibrosis J Hypertens 26 2008 2022 2029
29. J. Du, Y.Y. Fan, and H. Hitomi Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats Am J Physiol Ren Physiol 297 2009 F802 F808
30. N. Sugano, S. Wakino, and T. Kanda T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy Kidney Int 73 2008 826 834